RNA sequencing steps toward the first line
- PMID: 37096746
- DOI: 10.1002/cncr.34801
RNA sequencing steps toward the first line
Abstract
DNA is the sequence that codes for proteins. Messenger RNA is transcribed from the DNA sequence of genes and translated into protein. It can be difficult to predict how a change in the DNA sequence will affect messenger RNA and protein quantity and quality. DNA translocation changes can cause the joining of sequences from two different genes or different parts of the same gene. DNA sequencing is often used clinically to predict how DNA changes might affect proteins. Alternatively, RNA sequencing can be used as a more direct measure of the effect of DNA changes on the protein products. This sequencing is important for identifying changes in cancer that may indicate response to targeted therapy, prognosis, or diagnosis.
Keywords: RNA sequencing; biomarkers; fusion protein; next-generation sequencing (NGS); nonsmall cell lung cancer; splice variant; targeted therapy; translocation.
© 2023 American Cancer Society.
Comment on
-
Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer.Cancer. 2023 Aug 1;129(15):2422-2430. doi: 10.1002/cncr.34804. Epub 2023 Apr 25. Cancer. 2023. PMID: 37096747
Similar articles
-
Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patients.Thorac Cancer. 2020 Jul;11(7):1827-1834. doi: 10.1111/1759-7714.13460. Epub 2020 May 5. Thorac Cancer. 2020. PMID: 32372482 Free PMC article.
-
Identification of novel ALK fusions using DNA/RNA sequencing in immunohistochemistry / RT-PCR discordant NSCLC patients.Hum Pathol. 2021 Aug;114:90-98. doi: 10.1016/j.humpath.2021.05.005. Epub 2021 May 18. Hum Pathol. 2021. PMID: 34019866
-
Gene rearrangement detection by next-generation sequencing in patients with non-small cell lung carcinoma.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Jun;164(2):127-132. doi: 10.5507/bp.2020.015. Epub 2020 Apr 6. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020. PMID: 32284620 Review.
-
Identification of MET exon14 skipping by targeted DNA- and RNA-based next-generation sequencing in pulmonary sarcomatoid carcinomas.Lung Cancer. 2018 Aug;122:113-119. doi: 10.1016/j.lungcan.2018.06.001. Epub 2018 Jun 2. Lung Cancer. 2018. PMID: 30032818
-
[IHC, FISH, CISH, NGS in non-small cell lung cancer: What changes in the biomarker era?].Rev Pneumol Clin. 2018 Oct;74(5):327-338. doi: 10.1016/j.pneumo.2018.09.013. Epub 2018 Oct 19. Rev Pneumol Clin. 2018. PMID: 30343945 Review. French.
References
REFERENCES
-
- Latysheva NS , Babu MM . Discovering and understanding oncogenic gene fusions through data intensive computational approaches. Nucleic Acids Res. 2016;44(10):4487-4503. doi:10.1093/nar/gkw282
-
- Davies KD , Lomboy A , Lawrence CA , et al. DNA-based versus RNA-based detection of MET exon 14 skipping events in lung cancer. J Thorac Oncol. 2019;14(4):737-741. doi:10.1016/j.jtho.2018.12.020
-
- Li W , Liu Y , Li W , Chen L , Ying J . Intergenic breakpoints identified by DNA sequencing confound targetable kinase fusion detection in NSCLC. J Thorac Oncol. 2020;15(7):1223-1231. doi:10.1016/j.jtho.2020.02.023
-
- Li W , Wan R , Guo L , et al. Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer. BMC Med. 2022;20(1):160. doi:10.1186/s12916-022-02362-9
-
- Ju S , Cui Z , Hong Y , et al. Detection of multiple types of cancer driver mutations using targeted RNA sequencing in nonsmall cell lung cancer. Cancer. 2023;000:000-000. doi:10.1002/cncr.34804
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical